Biomarin Pharmaceutical Inc (BMRN) — Net Asset Quality Index
Biomarin Pharmaceutical Inc (BMRN) has a Net Asset Quality Index of 72.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $8.59 Billion minus total liabilities of $2.38 Billion yields net assets of $6.21 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Biomarin Pharmaceutical Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Biomarin Pharmaceutical Inc Net Asset Quality Index Over Time (1998–2025)
This chart shows how Biomarin Pharmaceutical Inc's Net Asset Quality Index has evolved across 28 annual periods from 1998 to 2025. As of March 2026, the index stands at 72.3%, representing net assets of $6.21 Billion against total assets of $8.59 Billion USD. Explore Biomarin Pharmaceutical Inc (BMRN) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Biomarin Pharmaceutical Inc (1998–2025)
The table below presents the year-by-year Net Asset Quality Index for Biomarin Pharmaceutical Inc from 1998 to 2025, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Biomarin Pharmaceutical Inc stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 80.2% | $6.09 Billion | $7.59 Billion | $1.51 Billion | ▼ -0.8 pp |
| 2024 | 81.0% | $5.66 Billion | $6.99 Billion | $1.33 Billion | ▲ +8.6 pp |
| 2023 | 72.4% | $4.95 Billion | $6.84 Billion | $1.89 Billion | ▲ +0.2 pp |
| 2022 | 72.2% | $4.60 Billion | $6.38 Billion | $1.77 Billion | ▲ +1.1 pp |
| 2021 | 71.1% | $4.27 Billion | $6.00 Billion | $1.73 Billion | ▲ +0.9 pp |
| 2020 | 70.2% | $4.11 Billion | $5.85 Billion | $1.74 Billion | ▲ +3.6 pp |
| 2019 | 66.6% | $3.12 Billion | $4.69 Billion | $1.57 Billion | ▼ -0.5 pp |
| 2018 | 67.0% | $2.97 Billion | $4.43 Billion | $1.46 Billion | ▲ +6.4 pp |
| 2017 | 60.6% | $2.81 Billion | $4.63 Billion | $1.82 Billion | ▼ -8.1 pp |
| 2016 | 68.7% | $2.77 Billion | $4.02 Billion | $1.26 Billion | ▲ +4.4 pp |
| 2015 | 64.4% | $2.40 Billion | $3.73 Billion | $1.33 Billion | ▲ +3.0 pp |
| 2014 | 61.4% | $1.53 Billion | $2.49 Billion | $962.56 Million | ▲ +1.6 pp |
| 2013 | 59.8% | $1.34 Billion | $2.24 Billion | $903.02 Million | ▼ -5.0 pp |
| 2012 | 64.8% | $1.02 Billion | $1.57 Billion | $552.58 Million | ▲ +5.6 pp |
| 2011 | 59.2% | $773.05 Million | $1.31 Billion | $532.66 Million | ▲ +2.4 pp |
| 2010 | 56.8% | $717.26 Million | $1.26 Billion | $545.37 Million | ▲ +21.7 pp |
| 2009 | 35.1% | $322.19 Million | $917.16 Million | $594.98 Million | ▲ +4.6 pp |
| 2008 | 30.5% | $276.68 Million | $906.70 Million | $630.02 Million | ▲ +7.5 pp |
| 2007 | 23.0% | $187.73 Million | $815.28 Million | $627.55 Million | ▼ -2.4 pp |
| 2006 | 25.4% | $117.80 Million | $463.44 Million | $345.63 Million | ▲ +65.1 pp |
| 2005 | -39.7% | $-77.46 Million | $195.30 Million | $272.76 Million | ▼ -10.5 pp |
| 2004 | -29.2% | $-67.98 Million | $232.97 Million | $300.94 Million | ▼ -75.2 pp |
| 2003 | 46.0% | $117.85 Million | $256.34 Million | $138.49 Million | ▼ -43.1 pp |
| 2002 | 89.1% | $98.54 Million | $110.62 Million | $12.07 Million | ▼ -3.8 pp |
| 2001 | 92.9% | $159.55 Million | $171.81 Million | $12.26 Million | ▲ +1.9 pp |
| 2000 | 91.0% | $69.99 Million | $76.93 Million | $6.94 Million | ▼ -4.0 pp |
| 1999 | 95.0% | $98.38 Million | $103.55 Million | $5.17 Million | ▲ +1.7 pp |
| 1998 | 93.3% | $29.40 Million | $31.51 Million | $2.11 Million | — |